Los Angeles, CA -- (SBWIRE) -- 03/16/2019 -- Heart valve disease occurs when heart valves do not work properly the way they should. The heart has four valves (the tricuspid, pulmonary, mitral, and aortic valves); these valves have tissue flaps that open and close at each heartbeat. The heart valve flaps make sure blood flows in the right direction through your heart's and to the rest of your body. Birth defects, age-related changes, infections, or other medical conditions can cause one or more of your heart valves to not open fully or to let blood leak back into the heart chambers. These conditions make your heart work harder and affect its ability to pump blood.
The normal invasive and MI procedures used by physicians often lead to complications like pleural effusion, arrhythmia, pleuritis, pericardial effusion, pericarditis, and infections in the lungs. This has led to physicians opting for minimally invasive catheter-based heart valve replacement surgery to reduce complications. Proven to be safe and efficient, these minimally invasive procedures reduce the need for blood transfusions, the risk of infections, hospital stays, and lead to rapid healing and recovery and better clinical outcome. As a result of their benefits, many cardiologists are opting these methods over invasive, and open heart surgeries and vendors have started manufacturing products for use during minimally invasive procedures. This increase in implementation of minimally invasive procedures is considered to be one of the primary drivers that will fuel the growth of this market in the coming years.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/988317/global-heart-valves-competition-analysis-report
The demand for heart valves in the US has been rising rapidly since 2013, which will likely continue during the forecast period. The incidence of heart valve diseases in the country is rising, particularly among people aged above 70. Heart valve replacement procedures are minimally invasive and are considered safe and efficient. Many people prefer these procedures to open-heart surgeries. Favorable reimbursement coverage by Medicare governs these procedures leading many vendors to focus on launching their products in the US. These vendors are conducting clinical trials to prove their products' safety and efficacy profiles and gain FDA approvals. Approval of these devices will help in increasing the overall market revenue of heart valves in the country and boost market's growth globally.
The global Heart Valves market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Heart Valves volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heart Valves market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Boston Scientific Corporation
On-X Life Technologies
Micro Interventional Devices
St. Jude Medical
Segment by Regions
Segment by Type
Transcatheter Heart Valves
Tissue Heart Valves
Mechanical Heart Valves
Segment by Application
Ambulatory Surgical Centers
Get Complete Report in your Inbox within 24 hours: https://www.qyresearch.com/customize-request/form/988317/global-heart-valves-competition-analysis-report
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.